Wörwag Pharma

Wörwag Pharma, established in 1971, is a German pharmaceutical company specializing in healthcare solutions. Headquartered in Böblingen, Germany, the company operates within the Pharmaceuticals and Healthcare sectors. Its core business revolves around developing and providing pharmaceutical preparations, with a focus on treatments for diabetic conditions, secondary diseases, and disease prevention. The company's product portfolio also includes preparations aimed at specific health positions and family well-being, underscoring a commitment to comprehensive patient care.

With a significant operational footprint, Wörwag Pharma maintains a presence across multiple locations, including its primary base in Böblingen. The company employs a workforce ranging from 500-1,000 employees, dedicated to advancing its pharmaceutical mission. This team is instrumental in the development, production, and distribution of its specialized medical products. For insights into the individuals driving these efforts, one can explore Meet Wörwag Pharma's team. The company's product development emphasizes therapeutic areas such as diabetic care and the management of chronic conditions.

Wörwag Pharma extends its reach globally, with 22 international branches strategically located across Asia, Europe, and South America, serving diverse markets. The company's revenue reached $180.2M, reflecting its substantial market presence. Its operations are geared towards B2B engagement and providing essential pharmaceutical products to international healthcare systems. The company's strategic positioning is further supported by its extensive network and focus on specialized medical treatments.